MARTEK BIOSCIENCES CORP — key financial figures for fiscal year 2010 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2010)

$450.0M

Net Income/Loss (FY2010)

$27.9M

Total Assets (FY2010)

$798.8M

Total Equity (FY2010)

$671.0M

Cash Flows from Operating Activities (FY2010)

$146.0M

Source: MARTEK BIOSCIENCES CORP 10-K filing (FY2010). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.